Metabotropic glutamate receptors and striatal synaptic plasticity: Implications for neurological diseases

Progress in Neurobiology

Volumn 74, Issue 5, 2004, Pages 271-300

  Gubellini, Paolo ^a   Pisani, Antonio ^b,c   Centonze, Diego ^b,c   Bernardi, Giorgio ^b,c   Calabresi, Paolo ^b,c  

^a CNRS   (France)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 2 (4 CARBOXYPHENYL) 3 (9 THIOXANTHYL)PROPIONIC ACID; 2 ARACHIDONOYLGLYCEROL; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 NITROPROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANANDAMIDE; BAY 367620; CALPHOSTIN C; CANNABINOID 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; EGLUMETAD; GLUTAMIC ACID; LIDOCAINE ETHOBROMIDE; LY 310225; LY 393675; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; QUINPIROLE; RIMONABANT; STAUROSPORINE; SULPIRIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BASAL GANGLION; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; DRUG ANTAGONISM; DRUG MECHANISM; GLUCOSE BRAIN LEVEL; HUMAN; ION CONDUCTANCE; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HUMANS; NERVOUS SYSTEM DISEASES; NEURAL NETWORKS (COMPUTER); NEURAL PATHWAYS; NEURONAL PLASTICITY; NEURONS; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 9744226444     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2004.09.005     Document Type: Review

References (300)

1. + conductance in rat neostriatal neurons Nature 344 1990 240 242
2. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of basal ganglia disorders Trends Neurosci. 12 1989 366 375
3. A. Alessandrini, S. Namura, and M.A. Moskowitz MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia Proc. Natl. Acad. Sci. U.S.A. 96 1999 12866 12869
4. T. Alexi, P.E. Hughes, B. Knusel, and A.J. Tobin Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice Exp. Neurol. 153 1998 74 93
5. M. Amalric, C. Baunez, and A. Nieoullon Does the blockade of excitatory amino acid transmission in the basal ganglia simply reverse reaction time deficits induced by dopamine inactivation? Behav. Pharmacol. 6 5-6 1995 508 519
6. L. Aniksztejn, S. Otani, and Y. Ben-Ari Quisqualate metabotropic receptors modulate NMDA currents and facilitate induction of long-term potentiation through protein kinase C Eur. J. Neurosci. 4 1992 500 505
7. T. Aosaki, A.M. Graybiel, and M. Kimura Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys Science 265 1994 412 415
8. T. Aosaki, K. Kiuchi, and Y. Kawaguchi Dopamine D1-like receptor activation excites rat striatal large aspiny neurons in vitro J. Neurosci. 18 1998 5180 5190
9. P. Apicella Tonically active neurons in the primate striatum and their role in the processing of information about motivationally relevant events Eur. J. Neurosci. 16 2002 2017 2026
10. I. Arai, T. Shimazoe, S. Shibata, H. Inoue, A. Yoshimatsu, and S. Watanabe Enhancement of dopamine release from the striatum through metabotropic glutamate receptor activation in methamphetamine sensitized rats Brain Res. 729 1996 277 280
11. M.A. Ariano, E.R. Larson, K.L. Noblett, D.R. Sibley, and M.S. Levine Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits Synapse 26 1997 400 414
12. A. Artola, and W. Singer Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation Trends Neurosci. 16 1993 480 487
13. S. Attarian, and M. Amalric Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat Eur. J. Neurosci. 9 1997 809 816
14. H. Awad, G.W. Hubert, Y. Smith, A.I. Levey, and P.J. Conn Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus J. Neurosci. 20 2000 7871 7879
15. G. Battaglia, V. Bruno, A. Pisani, D. Centonze, M.V. Catania, P. Calabresi, and F. Nicoletti Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing GABAergic transmission Mol. Cell. Neurosci. 17 2001 1071 1083
16. C. Baunez, A. Nieoullon, and M. Amalric In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit J. Neurosci. 15 1995 6531 6541
17. M.F. Beal, N.W. Kowall, D.W. Ellison, M.F. Mazurek, K.J. Swartz, and J.B. Martin Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 1986 168 171
18. M.F. Beal, E. Brouillet, B.G. Jenkins, R.J. Ferrante, N.W. Kowall, J.M. Miller, E. Storey, R. Srivastava, B.R. Rosen, and B.T. Hyman Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J. Neurosci. 10 1993 4181 4192
19. M.F. Beal, R.J. Ferrante, R. Henshaw, R.T. Matthews, P.H. Chan, N.W. Kowall, C.J. Epstein, and J.B. Schulz 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice J. Neurochem. 65 1995 919 922
20. M.F. Bear, and R.C. Malenka Synaptic plasticity: LTP and LTD Curr. Opin. Neurobiol. 4 1994 389 399
21. M.I. Behrens, J. Koh, L.M. Canzoniero, S.L. Sensi, C.A. Csernansky, and D.W. Choi 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons Neuroreport 6 1995 545 548
22. M.I. Bell, P.J. Richardson, and K. Lee Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurons J. Neurochem. 81 2002 142 149
23. P. Benquet, C.E. Gee, and U. Gerber Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes J. Neurosci. 22 2002 9679 9686
24. M.J. Berridge Neuronal calcium signaling Neuron 21 1998 13 26
25. T.V.P. Bliss, and T. Lømo Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path J. Physiol. 232 1973 331 356
26. J.J. Bouyer, D.H. Park, T.H. Joh, and V.M. Pickel Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum Brain Res. 302 1984 267 275
27. S.R. Bradley, D.G. Standaert, A.I. Levey, and P.J. Conn Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies Ann. N. Y. Acad. Sci. 868 1999 531 534
28. S.R. Bradley, M.J. Marino, M. Wittmann, S.T. Rouse, H. Awad, A.I. Levey, and P.J. Conn Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia nigra pars reticulata J. Neurosci. 20 2000 3085 3094
29. N. Breysse, C. Baunez, W. Spooren, F. Gasparini, and M. Amalric Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism J. Neurosci. 22 2002 5669 5678
30. N. Breysse, M. Amalric, and P. Salin Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats J. Neurosci. 23 2003 8302 8309
31. E. Brouillet, P. Hantraye, R.J. Ferrante, R. Dolan, A. Leroy-Willig, N.W. Kowall, and M.F. Beal Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates Proc. Natl. Acad. Sci. U.S.A. 92 1995 7105 7119
32. J.R. Brown, and G.W. Arbuthnott The electrophysiology of dopamine (D2) receptors: a study of the actions of dopamine on corticostriatal transmission Neuroscience 10 1983 349 355
33. S.E. Browne, A.C. Bowling, U. MacGarvey, M.J. Baik, S.C. Berger, M.M. Muqit, E.D. Bird, and M.F. Beal Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia Ann. Neurol. 41 1997 646 653
34. V. Bruno, A. Copani, T. Knopfel, R. Kuhn, G. Casabona, P. Dell'Albani, D.F. Condorelli, and F. Nicoletti Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells Neuropharmacology 34 1995 1089 1098
35. V. Bruno, G. Battaglia, G. Casabona, A. Copani, F. Caciagli, and F. Nicoletti Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta J. Neurosci. 18 1998 9594 9600
36. V. Bruno, G. Battaglia, A. Kingston, M.J. O'Neill, M.V. Catania, R. Di Grezia, and F. Nicoletti Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors Neuropharmacology 38 1999 199 207
37. V. Bruno, G. Battaglia, A. Copani, M. D'Onofrio, P. Di Iorio, A. De Blasi, D. Melchiorri, P.J. Flor, and F. Nicoletti Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs J. Cereb. Blood Flow Metab. 21 2001 1013 1033
38. A. Buisson, and D.W. Choi The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death Neuropharmacology 34 1995 1081 1087
39. P. Calabresi, N. Mercuri, P. Stanzione, A. Stefani, and G. Bernardi Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement Neuroscience 20 1987 757 771
40. P. Calabresi, N.B. Mercuri, and G. Bernardi Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis J. Neurophysiol. 63 1990 651 662
41. P. Calabresi, N.B. Mercuri, and G. Bernardi Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vitro analysis J. Neurophysiol. 63 1990 663 675
42. P. Calabresi, R. Maj, A. Pisani, N.B. Mercuri, and G. Bernardi Long-term synaptic depression in the striatum: physiological and pharmacological characterization J. Neurosci. 12 1992 4224 4233
43. P. Calabresi, A. Pisani, N.B. Mercuri, and G. Bernardi Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels Eur. J. Neurosci. 4 1992 929 935
44. P. Calabresi, R. Maj, N.B. Mercuri, and G. Bernardi Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum Neurosci. Lett. 142 1992 95 99
45. P. Calabresi, N.B. Mercuri, and G. Bernardi Activation of quisqualate metabotropic receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum Neurosci. Lett. 139 1992 41 44
46. P. Calabresi, N.B. Mercuri, G. Sancesario, and G. Bernardi Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease Brain 116 1993 433 452
47. P. Calabresi, A. Pisani, N.B. Mercuri, and G. Bernardi Heterogeneity of metabotropic glutamate receptors in the striatum: electrophysiological evidence Eur. J. Neurosci. 5 1993 1370 1377
48. P. Calabresi, A. Pisani, N.B. Mercuri, and G. Bernardi Post-receptor mechanisms underlying striatal long-term depression J. Neurosci. 14 1994 4871 4881
49. + ATPase Eur. J. Neurosci. 7 1995 1674 1683
50. P. Calabresi, E. Fedele, A. Pisani, G. Fontana, N.B. Mercuri, G. Bernardi, and M. Raiteri Transmitter release associated with long-term synaptic depression in rat corticostriatal slices Eur. J. Neurosci. 7 1995 1889 1894
51. P. Calabresi, A. Pisani, N.B. Mercuri, and G. Bernardi On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons Brain 118 1995 1027 1038
52. P. Calabresi, A. Pisani, N.B. Mercuri, and G. Bernardi The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia Trends Neurosci. 19 1996 19 24
53. P. Calabresi, M. De Murtas, and G. Bernardi The neostriatum beyond the motor function: experimental and clinical evidence Neuroscience 78 1997 39 60
54. P. Calabresi, A. Saiardi, A. Pisani, J.H. Baik, D. Centonze, N.B. Mercuri, G. Bernardi, and E. Borrelli Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors J. Neurosci. 17 1997 4536 4544
55. P. Calabresi, C.M. Ascone, D. Centonze, A. Pisani, G. Sancesario, V. D'Angelo, and G. Bernardi Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons J. Neurosci. 17 1997 1940 1949
56. P. Calabresi, D. Centonze, P. Gubellini, A. Pisani, and G. Bernardi Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation Eur. J. Neurosci. 10 1998 2887 2895
57. P. Calabresi, D. Centonze, P. Gubellini, A. Pisani, and G. Bernardi Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses Eur. J. Neurosci. 10 1998 3020 3023
58. P. Calabresi, D. Centonze, A. Pisani, G. Sancesario, P. Gubellini, G.A. Marfia, and G. Bernardi Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease Ann. Neurol. 43 1998 586 597
59. P. Calabresi, D. Centonze, P. Gubellini, and G. Bernardi Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP Neuropharmacology 38 1999 323 326
60. P. Calabresi, P. Gubellini, D. Centonze, G. Sancesario, M. Morello, M. Giorgi, A. Pisani, and G. Bernardi A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression J. Neurosci. 19 1999 2489 2499
61. P. Calabresi, D. Centonze, P. Gubellini, G.A. Marfia, and G. Bernardi Glutamate-triggered events inducing corticostriatal long-term depression J. Neurosci. 19 1999 6102 6110
62. P. Calabresi, D. Centonze, A. Pisani, and G. Bernardi Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease Exp. Neurol. 158 1999 97 108
63. P. Calabresi, G.A. Marfia, S. Amoroso, A. Pisani, and G. Bernardi Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons Stroke 30 1999 1687 1694
64. P. Calabresi, D. Centonze, and G. Bernardi Electrophysiology of dopamine in normal and denervated striatal neurons Trends Neurosci. 23 2000 S57 S63
65. P. Calabresi, P. Gubellini, D. Centonze, B. Picconi, G. Bernardi, K. Chergui, P. Svenningsson, A.A. Fienberg, and P. Greengard Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity J. Neurosci. 20 2000 8443 8451
66. P. Calabresi, D. Centonze, P. Gubellini, A. Pisani, and G. Bernardi Acetylcholine-mediated modulation of striatal function Trends Neurosci. 23 2000 120 126
67. P. Calabresi, D. Centonze, P. Gubellini, G.A. Marfia, A. Pisani, G. Sancesario, and G. Bernardi Synaptic transmission in the striatum: from plasticity to neurodegeneration Prog. Neurobiol. 61 2000 231 265
68. P. Calabresi, D. Centonze, and G. Bernardi Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum Neurology 55 2000 1249 1255
69. P. Calabresi, P. Gubellini, B. Picconi, D. Centonze, P. Greengard, R.A. Hipskind, E. Borrelli, and G. Bernardi Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine J. Neurosci. 21 2001 5110 5120
70. P. Calabresi, E. Saulle, G.A. Marfia, D. Centonze, R. Mulloy, B. Picconi, R.A. Hipskind, F. Conquet, and G. Bernardi Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum Mol. Pharmacol. 60 2001 808 815
71. P. Calabresi, E. Saulle, D. Centonze, A. Pisani, G.A. Marfia, and G. Bernardi Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability Brain 125 2002 844 860
72. P. Calabresi, D. Centonze, A. Pisani, L. Cupini, and G. Bernardi Synaptic plasticity in the ischaemic brain Lancet Neurol. 2 2003 622 629
73. C.J. Carter, R. L'Heureux, and B. Scatton Differential control by N-methyl-d-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study J. Neurochem. 51 1988 462 468
74. J. Cartmell, C.R. Salhoff, K.W. Perry, J.A. Monn, and D.D. Schoepp Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum Brain Res. 887 2000 378 384
75. J. Cartmell, and D.D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptors J. Neurochem. 75 2000 889 907
76. D. Centonze, P. Gubellini, B. Picconi, P. Calabresi, P. Giacomini, and G. Bernardi Unilateral dopamine denervation blocks corticostriatal LTP J. Neurophysiol. 82 1999 3575 3579
77. D. Centonze, A. Pisani, P. Bonsi, P. Giacomini, G. Bernardi, and P. Calabresi Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation J. Neurosci. 21 2001 1393 1400
78. D. Centonze, B. Picconi, P. Gubellini, G. Bernardi, and P. Calabresi Dopaminergic control of synaptic plasticity in the dorsal striatum Eur. J. Neurosci. 13 2001 1071 1077
79. D. Centonze, M. Napolitano, E. Saulle, P. Gubellini, B. Picconi, A. Martorana, A. Pisani, A. Gulino, G. Bernardi, and P. Calabresi Tissue plasminogen activator is required for corticostriatal long-term potentiation Eur. J. Neurosci. 16 2002 713 721
80. D. Centonze, P. Gubellini, A. Pisani, G. Bernardi, and P. Calabresi Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity Rev. Neurosci. 14 2003 207 216
81. D. Centonze, C. Grande, A. Usiello, P. Gubellini, E. Erbs, A.B. Martin, A. Pisani, N. Tognazzi, G. Bernardi, R. Moratalla, E. Borrelli, and P. Calabresi Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons J. Neurosci. 23 2003 6245 6254
82. C. Cepeda, N.A. Buchwald, and M.S. Levine Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated Proc. Natl. Acad. Sci. U.S.A. 90 1993 9576 9580
83. C. Cepeda, J.P. Walsh, W. Peacock, N.A. Buchwald, and M.S. Levine Neurophysiological, pharmacological and morphological properties of human caudate neurons recorded in vitro Neuroscience 59 1994 89 103
84. J.H. Cha, C.M. Kosinski, J.A. Kerner, S.A. Alsdorf, L. Mangiarini, S.W. Davies, J.B. Penney, G.P. Bates, and A.B. Young Proc. Natl. Acad. Sci. U.S.A. 95 1998 6480 6485
85. S. Charpier, and J.M. Deniau In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation Proc. Natl. Acad. Sci. U.S.A. 94 1997 7036 7040
86. S. Charpier, S. Mahon, and J.M. Deniau In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex Neuroscience 91 1999 1209 1222
87. T.N. Chase, and J.D. Oh Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism Trends Neurosci. 23 2000 S86 S91
88. M.-F. Chesselet, C. Gonzales, C.S. Lin, K. Polsky, and B.K. Jin Ischemic damage in the striatum of adult gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons Exp. Neurol. 110 1990 209 218
89. C. Chiamulera, M.P. Epping-Jordan, A. Zocchi, C. Marcon, C. Cottiny, S. Tacconi, M. Corsi, F. Orzi, and F. Conquet Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice Nat. Neurosci. 4 2001 873 874
90. S. Choi, and D.M. Lovinger Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses Proc. Natl. Acad. Sci. U.S.A. 94 1997 2665 2670
91. D.E. Clapham Calcium signaling Cell 80 1995 259 268
92. F. Conquet, Z.I. Bashir, C.H. Davies, H. Daniel, F. Ferraguti, F. Bordi, K. Franz-Bacon, A. Reggiani, V. Matarese, F. Condé, G.L. Collingridge, and F. Crépel Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1 Nature 372 1994 237 243
93. C. Corti, L. Aldegheri, P. Somogyi, and F. Ferraguti Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS Neuroscience 110 2002 403 420
94. R.L. Cowan, and C.J. Wilson Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex J. Neurophysiol. 71 1994 17 32
95. A. Cozzi, E. Meli, V. Carla, R. Pellicciari, F. Moroni, and D.E. Pellegrini-Giampietro Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? Neuropharmacology 43 2002 119 130
96. V. Crépel, C. Hammond, P. Chinestra, D. Diabira, and Y. Ben-Ari A selective LTP of NMDA receptor-mediated currents induced by anoxia in CA1 hippocampal neurons J. Neurophysiol. 70 1993 2045 2055
97. H.N. David, and J.H. Abraini The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens Eur. J. Neurosci. 13 2001 2157 2164
98. L. Dawson, A. Chadha, M. Megalou, and S. Duty The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat Br. J. Pharmacol. 129 2000 541 546
99. M. DeLong Primate models of movement disorders of basal ganglia Trends Neurosci. 13 1990 281 285
100. K.T. Dineley, E.J. Weeber, C. Atkins, J.P. Adams, A.E. Anderson, and J.D. Sweatt Leitmotifs in the biochemistry of LTP induction: amplification, integration and coordination J. Neurochem. 77 2001 961 971
101. A.J. Doherty, M.J. Palmer, J.M. Henley, G.L. Collingridge, and D.E. Jane (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus Neuropharmacology 36 1997 265 267
102. M.R. Domenici, A. Pintor, R.L. Potenza, S. Gaudi, M.C. Gro, F. Passarelli, R. Reggio, M. Galluzzo, M. Massotti, and P. Popoli Metabotropic glutamate receptor 5 (mGluR5)-mediated phosphoinositide hydrolysis and NMDA-potentiating effects are blunted in the striatum of aged rats: a possible additional mechanism in striatal senescence Eur. J. Neurosci. 17 2003 2047 2055
103. F. Dos Santos Villar, and J.P. Walsh Modulation of long-term synaptic plasticity at excitatory striatal synapses Neuroscience 90 1999 1031 1041
104. R. Duvoisin Cholinergic-anticholinergic antagonism in parkinsonism Arch. Neurol. 17 1967 124 136
105. M. Erecinska, and D. Nelson Effects of 3-nitropropionic acid on synaptosomal energy and transmitter metabolism: relevance to neurodegenerative brain diseases J. Neurochem. 63 1994 1033 1041
106. 2+ stores and ion channels in neurons Trends Neurosci. 23 2000 80 88
107. J.A. Feeley Kearney, and R.L. Albin mGluRs: a target for pharmacotherapy in Parkinson disease Exp. Neurol. 184 2003 S30 S36
108. F. Ferraguti, C. Pietra, E. Valerio, C. Corti, C. Chiamulera, and F. Conquet Evidence against a permissive role of the metabotropic glutamate receptor 1 in acute excitotoxicity Neuroscience 79 1997 1 5
109. F. Ferraguti, B. Baldani-Guerra, M. Corsi, S. Nakanishi, and C. Corti Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors Eur. J. Neurosci. 11 1999 2073 2082
110. R.J. Ferrante, N.W. Kowall, M.F. Beal, E.P. Richardson Jr., E.D. Bird, and J.B. Martin Selective sparing of a class of striatal neurons in Huntington's disease Science 230 1985 561 563
111. S.M. Fitzjohn, A.J. Irving, M.J. Palmer, J. Harvey, D. Lodge, and G.L. Collingridge Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices Neurosci. Lett. 203 1996 211 213 Erratum in: Neurosci. Lett. 207, 142
112. T.F. Freund, J.F. Powell, and A.D. Smith Tyrosine hydroxylase- immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines Neuroscience 13 1984 1189 1215
113. E. Galarraga, S. Hernandez-Lopez, A. Reyes, I. Miranda, F. Bermudez-Rattoni, C. Vilchis, and J. Bargas Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors J. Neurosci. 19 1999 3629 3638
114. M. Garcia-Munoz, S.J. Young, and P.M. Groves Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation Brain Res. 551 1991 195 206
115. M. Garcia-Munoz, P. Patino, E. Masliah, S.J. Young, and P.M. Groves Glutamate-dependent long-term presynaptic changes in corticostriatal excitability Neuroscience 73 1996 109 119
116. G. Gerdeman, and D.M. Lovinger CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum J. Neurophysiol. 85 2001 468 471
117. G.L. Gerdeman, J. Ronesi, and D.M. Lovinger Postsynaptic endocannabinoid release is critical to long-term depression in the striatum Nat. Neurosci. 5 2002 446 451
118. A. Ghosh, and M.E. Greenberg Calcium signaling in neurons: molecular mechanisms and cellular consequences Science 268 1995 239 247
119. K. Golembiowska, J. Konieczny, S. Wolfarth, and K. Ossowska Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats Neuropharmacology 45 2003 484 492
120. A.M. Graybiel Neurotransmitters and neuromodulators in the basal ganglia Trends Neurosci. 13 1990 133 154
121. A.M. Graybiel, T. Aosaki, A.W. Flaherty, and M. Kimura The basal ganglia and adaptive motor control Science 265 1994 1826 1831
122. J.T. Greenamyre, and C.F. O'Brien N-Methyl-d-aspartate antagonists in the treatment of Parkinson's disease Arch. Neurol. 48 1991 977 981
123. J.T. Greenamyre Glutamatergic influences on the basal ganglia Clin. Neuropharmacol. 24 2001 65 70
124. J.G. Greene, and J.T. Greenamyre Bioenergetics and glutamate excitotoxicity Prog. Neurobiol. 48 1996 613 634
125. J.G. Greene, R.H. Porter, R.V. Eller, and J.T. Greenamyre Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum J. Neurochem. 61 1993 1151 1154
126. J.G. Greene, S.S. Sheu, R.A. Gross, and J.T. Greenamyre 3-Nitropropionic acid exacerbates N-methyl-d-aspartate toxicity in striatal culture by multiple mechanisms Neuroscience 84 1998 503 510
127. P. Greengard, P.B. Allen, and A.C. Nairn Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade Neuron 23 1999 435 447
128. P.M. Groves A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement Brain Res. Rev. 5 1983 109 132
129. M. Gu, M.T. Gash, V.M. Mann, F. Javoy-Agid, J.M. Cooper, and A.H. Schapira Mitochondrial defect in Huntington's disease caudate nucleus Ann. Neurol. 39 1996 385 389
130. P. Gubellini, E. Saulle, D. Centonze, P. Bonsi, A. Pisani, G. Bernardi, F. Conquet, and P. Calabresi Selective involvement of mGlu1 receptors in corticostriatal LTD Neuropharmacology 40 2001 839 846
131. P. Gubellini, B. Picconi, M. Bari, N. Battista, P. Calabresi, D. Centonze, G. Bernardi, A. Finazzi-Agrò, and M. Maccarrone Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission J. Neurosci. 22 2002 6900 6907
132. P. Gubellini, E. Saulle, D. Centonze, C. Costa, D. Tropepi, G. Bernardi, F. Conquet, and P. Calabresi Corticostriatal LTP requires combined mGluR1 and mGluR5 activation Neuropharmacology 44 2003 8 16
133. P. Gubellini, D. Centonze, D. Tropepi, G. Bernardi, and P. Calabresi Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway Neuropharmacology 46 2004 761 769
134. J. Harvey, and G.L. Collingridge Signal transduction pathways involved in the acute potentiation of NMDA responses by 1S,3R-ACPD in rat hippocampal slices Br. J. Pharmacol. 109 1993 1085 1090
135. T. Hashimoto, N. Kitamura, N. Saito, O. Komure, N. Nishino, and C. Tanaka Brain Res. 585 1992 303 306
136. P. Henrich-Noack, C.D. Hatton, and K.G. Reymann The loss of beta II-protein kinase C in the striatum from patients with Huntington's disease NeuroReport 9 1998 985 988
137. H. Hidaka, and R. Kobayashi Pharmacology of protein kinase inhibitors Annu. Rev. Pharmacol. Toxicol. 32 1992 377 397
138. 2+ currents in rat striatal neurons through parallel pathways J. Neurosci. 15 1995 458 469
139. C.C. Huang, S.W. Lo, and K.S. Hsu Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons J. Physiol. 532 2001 731 748
140. K.S. Hsu, and C.C. Huang Characterization of the anoxia-induced long-term synaptic potentiation in area CA1 of the rat hippocampus Br. J. Pharmacol. 122 1997 671 681
141. R.J. Jakel, and W.F. Maragos Neuronal cell death in Huntington's disease: a potential role for dopamine Trends Neurosci. 23 2000 239 245
142. L. Kahn, G. Alonso, D. Robbe, J. Bockaert, and O.J. Manzoni Group 2 metabotropic glutamate receptors induced long-term depression in mouse striatal slices Neurosci. Lett. 316 2001 178 182
143. F. Karim, C.C. Wang, and R.W. Gereau IV Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice J. Neurosci. 21 2001 3771 3779
144. Y. Kawaguchi Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum J. Neurosci. 13 1993 4908 4923
145. Y. Kawaguchi, C.J. Wilson, S.J. Augood, and P.C. Emson Striatal interneurons: chemical, physiological and morphological characterization Trends Neurosci. 18 1995 527 535
146. L. Kerkerian, N. Dusticier, and A. Nieoullon Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum J. Neurochem. 48 1987 1301 1306
147. J.A. Kerner, D.G. Standaert, J.B. Penney Jr., A.B. Young, and G.B. Landwehrmeyer Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus Brain Res. Mol. Brain Res. 48 1997 259 269
148. J.N. Kerr, and J.R. Wickens Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro J. Neurophysiol. 85 2001 117 124
149. J.H. Kim, and P. Vezina Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion J. Pharmacol. Exp. Ther. 284 1998 317 322
150. G.W. Kim, J.C. Copin, M. Kawase, S.F. Chen, S. Sato, G.T. Gobbel, and P.H. Chan Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid J. Cereb. Blood Flow Metab. 20 2000 119 129
151. M. Kimura, J. Rajkowski, and E. Evarts Tonically discharging putamen neurons exhibit set-dependent responses Proc. Natl. Acad. Sci. U.S.A. 81 1984 4998 5001
152. A.E. Kingston, P.L. Ornstein, R.A. Wright, B.G. Johnson, N.G. Mayne, J.P. Burnett, R. Belagaje, S. Wu, and D.D. Schoepp LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors Neuropharmacology 37 1998 1 12
153. T. Klockgether, and L. Turski NMDA antagonists potentiate antiparkinsonian actions of l-dopa in monoamine-depleted rats Ann. Neurol. 28 1990 539 546
154. E. Kobayashi, H. Nakano, M. Morimoto, and T. Tamaoki Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C Biochem. Biophys. Res. Commun. 159 1989 548 553
155. S.B. Kombian, and R.C. Malenka Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens Nature 368 1994 242 246
156. J. Konieczny, K. Ossowska, S. Wolfarth, and A. Pilc LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats Naunyn Schmiedebergs Arch. Pharmacol. 358 1998 500 502
157. C.M. Kosinski, S. Risso Bradley, P.J. Conn, A.I. Levey, G.B. Landwehrmeyer, J.B. Penney Jr., A.B. Young, and D.G. Standaert Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia J. Comp. Neurol. 415 1999 266 284
158. R. Kotter Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum Prog. Neurobiol. 44 1994 163 196
159. N.V. Kulagina, M.J. Zigmond, and A.C. Michael Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum Neuroscience 102 2001 121 128
160. M.A. La Fontaine, J.W. Geddes, A. Banks, and D.A. Butterfield 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease Brain Res. 858 2000 356 362
161. J.M. Lee, G.J. Zipfel, and D.W. Choi The changing landscape of ischaemic brain injury mechanisms Nature 399 Suppl. 6738 1999 A7 A14
162. R. Levy, L.N. Hazrati, M.T. Herrero, M. Vila, O.K. Hassani, M. Mouroux, M. Ruberg, H. Asensi, Y. Agid, J. Feger, J.A. Obeso, A. Parent, and E.C. Hirsch Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states Neuroscience 76 1997 335 343
163. E. Lorenc-Koci, J. Wardas, S. Wolfarth, and A. Pilc (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats Brain Res. 903 2001 177 184
164. D.M. Lovinger Trans-1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) decreases synaptic excitation in rat striatal slices through a presynaptic action Neurosci. Lett. 129 1991 17 21
165. D.M. Lovinger, E.C. Tyler, and A. Merritt Short- and long-term synaptic depression in rat neostriatum J. Neurophysiol. 70 1993 1937 1949
166. D.M. Lovinger, and B.A. McCool Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGluR2 or 3 J. Neurophysiol. 73 1995 1076 1083
167. D.M. Lovinger, and E. Tyler Synaptic transmission and modulation in the neostriatum Int. Rev. Neurobiol. 39 1996 77 111
168. D.M. Lovinger, K.W. Sung, J. Partridge, and K.C. Tang Different glutamate receptors play crucial roles in induction of long-lasting changes in synaptic efficacy at corticostriatal synapse Neuropharmacology 38 1999 A27
169. D.M. Lovinger, J.G. Partridge, and K.C. Tang Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse J. Neurophysiol. 84 2000 1422 1429
170. A.C. Ludolph, F. He, P.S. Spencer, J. Hammerstad, and M. Sabri 3-Nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin Can. J. Neurol. Sci. 18 1991 492 498
171. M. Maccarrone, P. Gubellini, M. Bari, B. Picconi, N. Battista, D. Centonze, G. Bernardi, A. Finazzi-Agrò, and P. Calabresi Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission J. Neurochem. 85 2003 1018 1025
172. N. MacInnes, M.J. Messenger, and S. Duty Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat Br. J. Pharmacol. 141 2004 15 22
173. S. Mahon, J.M. Deniau, and S. Charpier Corticostriatal plasticity: life after the depression Trends Neurosci. 27 2004 460 467
174. O. Manzoni, J. Michel, and J. Bockaert Metabotropic glutamate receptors in the rat nucleus accumbens Eur. J. Neurosci. 9 1997 1514 1523
175. L. Mao, Y.S. Lau, and J.Q. Wang Activation of group III metabotropic glutamate receptors inhibits basal and amphetamine-stimulated dopamine release in rat dorsal striatum: an in vivo microdialysis study Eur. J. Pharmacol. 404 2000 289 297
176. M.J. Marino, and J.P. Conn Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeutics Curr. Drug Target CNS Neurol. Dis. 1 2002 239 250
177. M. Marti, F. Paganini, S. Stocchi, C. Bianchi, L. Beani, and M. Morari Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release Eur. J. Neurosci. 14 2001 1181 1184
178. P.R. Mitchell, and N.S. Doggett Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs Life Sci. 26 1980 2073 2081
179. I.J. Mitchell, and C.B. Carroll Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action Neurosci. Biobehav. Rev. 21 1997 469 475
180. I.J. Mitchell, A.J. Cooper, and M.R. Griffiths The selective vulnerability of striatopallidal neurons Prog. Neurobiol. 59 1999 691 719
181. R.X. Moldrich, and P.M. Beart Emerging signalling and protein interactions mediated via metabotropic glutamate receptors Curr. Drug Targets CNS Neurol. Disord. 2 2003 109 122
182. M. Morari, W.T. O'Connor, U. Ungerstedt, and K. Fuxe N-Methyl-d-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study J. Neurochem. 60 1993 1884 1893
183. B.J. Morris, C.S. Simpson, S. Mundell, K. Maceachern, H.M. Johnston, and A.M. Nolan Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release Neuropharmacology 36 1997 1589 1599
184. A.N. Murphy, G. Fiskum, and M.F. Beal Mitochondria in neurodegeneration: bioenergetic function in cell life and death J. Cereb. Blood Flow Metab. 19 1999 231 245
185. T.K. Murray, M.J. Messenger, M.A. Ward, S. Woodhouse, D.J. Osborne, S. Duty, and M.J. O'Neill Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease Pharmacol. Biochem. Behav. 73 2002 455 466
186. S. Nakanishi Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity Neuron 13 1994 1031 1037
187. M. Napolitano, D. Centonze, P. Gubellini, S. Rossi, S. Spiezia, G. Bernardi, A. Gulino, and P. Calabresi Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease Neurobiol. Dis. 15 2004 407 414
188. 2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid Neurochem. Int. 43 2003 89 99
189. F. Nicoletti, V. Bruno, M.V. Catania, G. Battaglia, A. Copani, G. Barbagallo, V. Cena, J. Sanchez-Prieto, P.F. Spano, and M. Pizzi Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection Neuropharmacology 38 1999 1477 1484
190. A. Nieoullon Dopamine and the regulation of cognition and attention Prog. Neurobiol. 67 2002 53 83
191. K. Nishi, P.T. Atkins, D.J. Surmeier, and S.T. Kitai Muscarinic regulation of cyclic AMP metabolism in rat neostriatal cultures Brain Res. 534 1990 111 116
192. H. Ohishi, R. Shigemoto, S. Nakanishi, and N. Mizuno Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study J. Comp. Neurol. 335 1993 252 266
193. M. Ohno, and S. Watanabe Persistent increase in dopamine release following activation of metabotropic glutamate receptors in the rat nucleus accumbens Neurosci. Lett. 200 1995 113 116
194. L.R. Orlando, D.G. Standaert, J.B. Penney, and A.B. Young Metabotropic receptors in excitotoxicity: (S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG) protects against rat striatal quinolinic acid lesions Neurosci. Lett. 202 1995 109 112
195. K. Ossowska, J. Konieczny, S. Wolfarth, J. Wieronska, and A. Pilc Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats Neuropharmacology 41 2001 413 420
196. K. Ossowska, J. Konieczny, J. Wardas, K. Golembiowska, S. Wolfarth, and A. Pilc The role of striatal metabotropic glutamate receptors in Parkinson's disease Amino Acids 23 2002 193 198
197. O.P. Ottersen, and A.S. Landsend Organization of glutamate receptors at the synapse Eur. J. Neurosci. 9 1997 2219 2224
198. S. Palfi, R.J. Ferrante, E. Brouillet, M.F. Beal, R. Dolan, M.C. Guyot, M. Peschanski, and P. Hantraye Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease J. Neurosci. 16 1996 3019 3025
199. Z. Pang, and J.W. Geddes Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis J. Neurosci. 17 1997 3064 3073
200. Z. Pang, V. Bondada, T. Sengoku, R. Siman, and J.W. Geddes Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology J. Neuropathol. Exp. Neurol. 62 2003 633 643
201. S.M. Papa, R.C. Boldry, T.M. Engber, A.M. Kask, and T.N. Chase Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade Brain Res. 701 1995 13 18
202. M.R. Park, J.W. Lighthall, and S.T. Kitai Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study Brain Res. 194 1980 359 369
203. A. Parker, and D. Gaffan Memory after frontal/temporal disconnection in monkeys: conditional and non-conditional tasks, unilateral and bilateral frontal lesions Neuropsychologia 36 1998 259 271
204. J.G. Partridge, K.C. Tang, and D.M. Lovinger Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum J. Neurophysiol. 84 2000 1422 1429
205. J.G. Partridge, S. Apparsundaram, G.A. Gerhardt, J. Ronesi, and D.M. Lovinger Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression J. Neurosci. 22 2002 2541 2549
206. R.D. Peavy, and P.J. Conn Phosphorylation of mitogen-activated protein kinase in cultured rat cortical glia by stimulation of metabotropic glutamate receptors J. Neurochem. 71 1998 603 612
207. D.E. Pellegrini-Giampietro, F. Peruginelli, E. Meli, A. Cozzi, S. Albani-Torregrossa, R. Pellicciari, and F. Moroni Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms Neuropharmacology 38 1999 1607 1619
208. C.M. Pennartz, R.F. Ameerun, H.J. Groenewegen, and F.H. Lopes da Silva Synaptic plasticity in an in vitro slice preparation of the rat nucleus accumbens Eur. J. Neurosci. 5 1993 107 117
209. E.K. Perry The cholinergic hypothesis - ten years on Br. Med. Bull. 42 1986 63 69
210. B. Picconi, A. Pisani, D. Centonze, G. Battaglia, M. Storto, F. Nicoletti, G. Bernardi, and P. Calabresi Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment Brain 125 2002 2635 2645
211. B. Picconi, D. Centonze, K. Hakansson, G. Bernardi, P. Greengard, G. Fisone, M.A. Cenci, and P. Calabresi Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia Nat. Neurosci. 6 2003 501 506
212. J.P. Pin, and F. Acher The metabotropic glutamate receptors: structure, activation mechanism and pharmacology Curr. Drug Target CNS Neurol. Dis. 1 2002 297 317
213. A. Pisani, P. Calabresi, D. Centonze, and G. Bernardi Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurons Br. J. Pharmacol. 120 1997 1007 1014
214. A. Pisani, P. Calabresi, D. Centonze, and G. Bernardi Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse Neuropharmacology 36 1997 845 851
215. A. Pisani, G. Bernardi, P. Bonsi, D. Centonze, P. Giacomini, and P. Calabresi Cell-type specificity of mGluR activation in striatal neuronal subtypes Amino Acids 19 2000 119 129
216. A. Pisani, P. Bonsi, D. Centonze, G. Bernardi, and P. Calabresi Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons Neuropharmacology 40 2001 460 463
217. A. Pisani, P. Gubellini, P. Bonsi, F. Conquet, B. Picconi, D. Centonze, G. Bernardi, and P. Calabresi Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons Neuroscience 106 2001 579 587
218. A. Pisani, P. Bonsi, M.V. Catania, R. Giuffrida, M. Morari, M. Marti, D. Centonze, G. Bernardi, A.E. Kingston, and P. Calabresi Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons J. Neurosci. 22 2002 6176 6185
219. A. Pisani, P. Bonsi, D. Centonze, P. Gubellini, G. Bernardi, and P. Calabresi Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors Neuropharmacology 45 2003 45 56
220. M. Pizzi, O. Consolandi, M. Memo, and P.F. Spano Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices Eur. J. Neurosci. 8 1996 1516 1521
221. W.H. Poewe, A.J. Lees, and G.M. Stern Low-dose l-dopa therapy in Parkinson's disease: a 6-year follow-up study Neurology 36 1986 1528 1530
222. O.V. Poisik, G. Mannaioni, S. Traynelis, Y. Smith, and P.J. Conn Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus J. Neurosci. 23 2003 122 130
223. R.J. Preston, G.A. Bishop, and S.T. Kitai Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study Brain Res. 183 1979 253 258
224. W.A. Pulsinelli Selective neuronal vulnerability: morphological and molecular characteristics Prog. Brain Res. 63 1985 29 37
225. O. Rascol The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease J. Neurol. 247 Suppl. 2 2000 II51 II57
226. A. Raz, A. Feingold, V. Zelanskaya, E. Vaadia, and H. Bergman Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates J. Neurophysiol. 76 1996 2083 2088
227. A. Raz, V. Frechter-Mazar, A. Feingold, M. Abeles, E. Vaadia, and H. Bergman Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys J. Neurosci. 21 2001 RC128
228. P.H. Reddy, M. Williams, and D.A. Tagle Recent advances in understanding the pathogenesis of Huntington's disease Trends Neurosci. 22 1999 248 255
229. J.N. Reynolds, and J.R. Wickens Substantia nigra dopamine regulates synaptic plasticity and membrane potential fluctuations in the rat neostriatum, in vivo Neuroscience 99 2000 199 203
230. N.C. Reynolds Jr., W. Lin, C. Meyer Cameron, and D.L. Roerig Differential responses of extracellular GABA to intrastriatal perfusions of 3-nitropropionic acid and quinolinic acid in the rat Brain Res. 778 1997 140 149
231. D.S. Reynolds, R.J. Carter, and A.J. Morton Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease J. Neurosci. 18 1998 10116 10127
232. 2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses J. Neurosci. 22 2002 4346 4356
233. D. Robbe, M. Kopf, A. Remaury, J. Bockaert, and O.J. Manzoni Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens Proc. Natl. Acad. Sci. U.S.A. 99 2002 8384 8388
234. S. Robinson, L. Krentz, C. Moore, and C.K. Meshul Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats Synapse 42 2001 54 61
235. J. Ronesi, G.L. Gerdeman, and D.M. Lovinger Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport J. Neurosci. 24 2004 1673 1679
236. S.T. Rouse, M.J. Marino, S.R. Bradley, H. Awad, M. Wittmann, and P.J. Conn Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders Pharmacol. Ther. 88 2000 427 435
237. G.F. Rowlands, and P.J. Roberts Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro Eur. J. Pharmacol. 62 1980 241 242
238. A.I. Sacaan, F.P. Bymaster, and D.D. Schoepp Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine J. Neurochem. 59 1992 245 251
239. Y. Sagara, and D. Schubert The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress J. Neurosci. 18 1998 6662 6671
240. S. Sato, G.T. Gobbel, J. Honkaniemi, Y. Li, T. Kondo, K. Murakami, M. Sato, J.C. Copin, and P.H. Chan Apoptosis in the striatum of rats following intraperitoneal injection of 3-nitropropionic acid Brain Res. 745 1997 343 347
241. S. Sato, G.T. Gobbel, J. Honkaniemi, Y. Li, T. Kondo, K. Murakami, M. Sato, J.C. Copin, F.R. Sharp, and P.H. Chan Decreased expression of bcl-2 and bcl-x mRNA coincides with apoptosis following intracerebral administration of 3-nitropropionic acid Brain Res. 808 1998 56 64
242. E. Saulle, D. Centonze, A.B. Martin, R. Moratalla, G. Bernardi, and P. Calabresi Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors Stroke 33 2002 2978 2984
243. E. Saulle, P. Gubellini, B. Picconi, D. Centonze, D. Tropepi, A. Pisani, M. Morari, M. Marti, L. Rossi, M. Papa, G. Bernardi, and P. Calabresi Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease Mol. Cell. Neurosci. 25 2004 9 20
244. K.A. Schinkmann, T.A. Kim, and S. Avraham Glutamate-stimulated activation of DNA synthesis via mitogen-activated protein kinase in primary astrocytes: involvement of protein kinase C and related adhesion focal tyrosine kinase J. Neurochem. 74 2000 1931 1940
245. D. Schoepp, J. Bockaert, and F. Sladeczek Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors Trends Pharmacol. Sci. 11 1990 508 515
246. D.D. Schoepp, and P.J. Conn Metabotropic glutamate receptors in brain function and pathology Trends Pharmacol. Sci. 14 1993 13 20
247. D.D. Schoepp, D.E. Jane, and J.A. Monn Pharmacological agents acting at subtypes of metabotropic glutamate receptors Neuropharmacology 38 1999 1431 1476
248. R.K.W. Schwarting, and J.P. Huston The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments Prog. Neurobiol. 50 1996 275 331
249. A. Senkowska, and K. Ossowska Role of metabotropic glutamate receptors in animal models of Parkinson's disease Pol. J. Pharmacol. 55 2003 935 950
250. S.R. Sesack, C. Aoki, and V.M. Pickel Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets J. Neurosci. 14 1994 88 106
251. T. Shimazoe, Y. Doi, I. Arai, A. Yoshimatsu, T. Fukumoto, and S. Watanabe Both metabotropic glutamate I and II receptors mediate augmentation of dopamine release from the striatum in methamphetamine-sensitized rats Jpn. J. Pharmacol. 89 2002 85 88
252. V.A. Skeberdis, J. Lan, T. Opitz, X. Zheng, M.V. Bennett, and R.S. Zukin mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C Neuropharmacology 40 2001 856 865
253. A.D. Smith, and J.P. Bolam The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons Trends Neurosci. 13 1990 259 265
254. Y. Smith, A. Charara, J.E. Hanson, M. Paquet, and A.I. Levey GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates J. Anat. 196 2000 555 576
255. R. Smith, W. Musleh, G. Akopian, G. Buckwalter, and J.P. Walsh Regional differences in the expression of corticostriatal synaptic plasticity Neuroscience 106 2001 95 101
256. B. Sommer, and P.H. Seeburg Glutamate receptor channels: novel properties and new clones Trends Pharmacol. Sci. 13 1992 291 296
257. J.P. Spencer, and K.P. Murphy Bi-directional changes in synaptic plasticity induced at corticostriatal synapses in vitro Exp. Brain Res. 135 2000 497 503
258. W.P. Spooren, F. Gasparini, T.E. Salt, and R. Kuhn Novel allosteric antagonists shed light on mglu5 receptors and CNS disorders Trends Pharmacol. Sci. 22 2001 331 337
259. D.G. Standaert, I.K. Friberg, G.B. Landwehrmeyer, A.B. Young, and J.B. Penney Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat Brain Res. Mol. Brain Res. 64 1999 11 23
260. D.G. Standaert, C.M. Testa, A.B. Young, and J.B. Penney Jr. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat J. Comp. Neurol. 343 1994 1 16
261. M.S. Starr Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease Synapse 19 1995 264 293
262. A. Stefani, A. Pisani, N.B. Mercuri, and P. Calabresi The modulation of calcium currents by the activation of mGluRs. Functional implications Mol. Neurobiol. 13 1996 81 95
263. E.A. Stern, D. Jaeger, and C.J. Wilson Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo Nature 394 1998 475 478
264. U. Strasser, D. Lobner, M.M. Behrens, L.M. Canzoniero, and D.W. Choi Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures Eur. J. Neurosci. 10 1998 2848 2855
265. T. Sugino, K. Nozaki, T. Tokime, N. Hashimoto, and H. Kikuchi 3-Nitropropionic acid induces poly(ADP-ribosyl)ation and apoptosis related gene expression in the striatum in vivo Neurosci. Lett. 237 1997 121 124
266. T. Sugino, K. Nozaki, Y. Takagi, I. Hattori, N. Hashimoto, T. Moriguchi, and E. Nishida Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus J. Neurosci. 20 2000 4506 4514
267. K.W. Sung, S. Choi, and D.M. Lovinger Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses J. Neurophysiol. 86 2001 2405 2412
268. T. Suzuki, M. Miura, K. Nishimura, and T. Aosaki Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons J. Neurosci. 21 2001 6492 6501
269. C.J. Swanson, and P.W. Kalivas Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area J. Pharmacol. Exp. Ther. 292 2000 406 414
270. J.D. Sweatt The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory J. Neurochem. 76 2001 1 10
271. M.T. Taber, and H.C. Fibiger Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors J. Neurosci. 15 1995 3896 3904
272. + conductance by metabotropic glutamate receptor in acutely dissociated large cholinergic neurons of rat caudate putamen J. Neurophysiol. 76 1996 1545 1558
273. S.J. Tallaksen-Greene, K.W. Kaatz, C. Romano, and R.L. Albin Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons Brain Res. 780 1998 210 217
274. K. Tang, M.J. Low, D.K. Grandy, and D.M. Lovinger Dopamine-dependent synaptic plasticity in striatum during in vivo development Proc. Natl. Acad. Sci. U.S.A. 98 2001 1255 1260
275. F.I. Tarazi, A. Campbell, S.K. Yeghiayan, and R.J. Baldessarini Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors Synapse 30 1998 227 235
276. C.M. Testa, D.G. Standaert, A.B. Young, and J.B. Penney Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat J. Neurosci. 14 1994 3005 3018
277. C.M. Testa, D.G. Standaert, G.B. Landwehrmeyer, J.B. Penney Jr., and A.B. Young Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons J. Comp. Neurol. 354 1995 241 252
278. C.M. Testa, I.K. Friberg, S.W. Weiss, and D.G. Standaert Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia J. Comp. Neurol. 390 1998 5 19
279. T.J. Teyler, and P. DiScenna Long-term potentiation as a candidate mnemonic device Brain Res. 7 1984 15 28
280. S. Thandi, J.L. Blank, and R.A. Challiss Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways J. Neurochem. 83 2002 1139 1153
281. N.K. Thomas, D.E. Jane, H.W. Tse, and J.C. Watkins Alpha-methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate receptor antagonists Neuropharmacology 35 1996 637 642
282. O. Valenti, P.J. Conn, and M.J. Marino Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populations J. Cell. Physiol. 191 2002 125 137
283. A. Verma, and B. Moghaddam Regulation of striatal dopamine release by metabotropic glutamate receptors Synapse 28 1998 220 226
284. J.P. Walsh Depression of excitatory synaptic input in rat striatal neurons Brain Res. 608 1993 123 128
285. D.M. Weiner, A.I. Levey, and M.R. Brann Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia Proc. Natl. Acad. Sci. U.S.A. 87 1990 7050 7054
286. T. Wichmann, and M.R. DeLong Functional neuroanatomy of the basal ganglia in Parkinson's disease Adv. Neurol. 91 2003 9 18
287. J.R. Wickens, A.J. Begg, and G.W. Arbuthnott Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro Neuroscience 70 1996 1 5
288. J.R. Wickens, D. Mckenzie, E. Costanzo, and G.W. Arbuthnott Effects of potassium channel blockers on synaptic plasticity in the corticostriatal pathway Neuropharmacology 37 1998 523 533
289. D.G. Winder, and P.J. Conn Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication J. Neurosci. Res. 46 1996 131 137
290. S.E. Wilkinson, P.J. Parker, and J.S. Nixon Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C Biochem. J. 294 1993 335 337
291. C.J. Wilson, and P.M. Groves Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase J. Comp. Neurol. 194 1980 599 615
292. C.J. Wilson, H.T. Chang, and S.T. Kitai Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum J. Neurosci. 10 1990 508 519
293. C.J. Wilson, and Y. Kawaguchi The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons J. Neurosci. 16 1996 2397 2410
294. U. Wullner, A.B. Young, J.B. Penney, and M.F. Beal 3-Nitropropionic acid toxicity in the striatum J. Neurochem. 63 1994 1772 1781
295. Z. Xia, H. Dudek, C.K. Miranti, and M.E. Greenberg Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism J. Neurosci. 16 1996 5425 5436
296. H. Yamada, T. Momose, M. Okada, and Y. Kuroiwa Anticholinergic drugs: response of parkinsonism not responsive to levodopa J. Neurol. Neurosurg. Psychiatry 72 2002 111 113
297. Z. Yan, J. Feng, A.A. Fienberg, and P. Greengard D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons Proc. Natl. Acad. Sci. U.S.A. 96 1999 11607 11612
298. 2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway J. Neurophysiol. 77 1997 1003 1015
299. W. Zhang, A.S. Basile, J. Gomeza, L.A. Volpicelli, A.I. Levey, and J. Wess Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice J. Neurosci. 22 2002 1709 1717
300. H. Zhang, and D. Sulzer Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors J. Neurosci. 23 2003 10585 10592